Search Results - "Piras, B."

Refine Results
  1. 1
  2. 2
  3. 3

    Systemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction by Piras, B A, Tian, Y, Xu, Y, Thomas, N A, O'Connor, D M, French, B A

    Published in Gene therapy (01-05-2016)
    “…Adeno-associated virus (AAV) has been used to direct gene transfer to a variety of tissues, including heart, liver, skeletal muscle, brain, kidney and lung,…”
    Get full text
    Journal Article
  4. 4

    Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? by Madeddu, G., Fois, A. G., Calia, G. M., Babudieri, S., Soddu, V., Becciu, F., Fiori, M. L., Spada, V., Lovigu, C., Mannazzu, M., Caddeo, A., Piras, B., Pirina, P., Mura, M. S.

    Published in Infection (01-04-2013)
    “…Purpose The objective of our study was to evaluate the presence of respiratory symptoms and chronic obstructive pulmonary disease (COPD) in a human…”
    Get full text
    Journal Article
  5. 5

    Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery by Katwal, A B, Konkalmatt, P R, Piras, B A, Hazarika, S, Li, S S, John Lye, R, Sanders, J M, Ferrante, E A, Yan, Z, Annex, B H, French, B A

    Published in Gene therapy (01-09-2013)
    “…Targeting therapeutic gene expression to the skeletal muscle following intravenous (IV) administration is an attractive strategy for treating peripheral…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients by Madeddu, G, Spanu, A, Solinas, P, Babudieri, S, Calia, G M, Lovigu, C, Mannazzu, M, Nuvoli, S, Piras, B, Bagella, P, Mura, M S, Madeddu, G

    “…To evaluate the changes in Bone Mineral Density (BMD) and bone remodelling markers in a group of HIV patients treated with HAART and controlled in a long…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier by Mais, V, Ajossa, S, Piras, B, Guerriero, S, Marongiu, D, Melis, G B

    Published in Human reproduction (Oxford) (01-12-1995)
    “…To evaluate the effectiveness of the oxidized regenerated cellulose absorbable barrier (Interceed, TC7) in the prevention of de-novo adhesion formation after…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) by Kieffer, Jacobien M., Postma, Tjeerd J., van de Poll-Franse, Lonneke, Mols, Floortje, Heimans, Jan J., Cavaletti, Guido, Aaronson, Neil K.

    Published in Quality of life research (01-11-2017)
    “…Purpose To investigate the scale structure and psychometrics of the EORTC chemotherapy-induced peripheral neuropathy module (QLQ-CIPN20). Methods Using…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data by Neri, Manuela, Melis, Gian Benedetto, Giancane, Elena, Vallerino, Valerio, Pilloni, Monica, Piras, Bruno, Loddo, Alessandro, Paoletti, Anna Maria, Mais, Valerio

    Published in International journal of women's health (01-10-2019)
    “…Uterine fibroids (UFs) are the most common gynaecological benign disease. Even though often asymptomatic, UFs can worsen women's health and their quality of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy by Binda, Davide, Cavaletti, Guido, Cornblath, David R., Merkies, Ingemar S. J.

    Published in Journal of the peripheral nervous system (01-09-2015)
    “…Composite scales such as the Total Neuropathy Score clinical version (TNSc©) have been widely used to measure neurological impairment in a standardized manner…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20